PARIS--(BUSINESS WIRE)--EOS imaging (Paris:EOSI)(Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced that it has acquired the rights to an exclusive, worldwide license for a technology dedicated to the prognosis of adolescent scoliosis using 3D and 2D clinical parameters obtained from EOS® systems. A multi-center clinical study has launched in 8 centers equipped with EOS systems (in the United States, Canada, France, Japan, Singapore and Hong Kong) t
![image](http://ads.pheedo.com/img.phdo?s=6ec55bd875f90da463322411b693594e&p=1)
![image](http://tags.bluekai.com/site/5148)
< Prev | Next > |
---|